Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001722024-21-000006
Filing Date
2021-05-26
Accepted
2021-05-26 21:59:18
Documents
1
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162208073560596.html 3  
1 FORM 3 wf-form3_162208073560596.xml 3 4184
  Complete submission text file 0001722024-21-000006.txt   5764
Mailing Address 26 NORTH EUCLID AVENUE PASADENA CA 91101
Business Address 26 NORTH EUCLID AVENUE PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40443 | Film No.: 21968359

Mailing Address 10931 N. TORREY PINES ROAD, SUITE #100 LA JOLLA CA 92037
Business Address 10931 N. TORREY PINES ROAD, SUITE #100 LA JOLLA CA 92037 (858) 333-7830
Singular Genomics Systems, Inc. (Issuer) CIK: 0001850906 (see all company filings)

EIN.: 812948451 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments